Fibroadenomatoid hyperplasia of the breast (FAHB) is a rare benign breast lesion and its clinical features are similar to fibroadenoma and fibrocystic changes. FAHB has been previously termed sclerosing lobular hyperplasia, fibroadenomatosis, fibroadenomatoid change, or fibroadenomatoid mastopathy. Typically, FAHB is derived from stroma and epithelia. The pathologic characteristics of FAHB are microfocal lobulocentric proliferation of stroma accompanied by epithelial and myoepithelial components resembling similar histological changes, as found in fibroadenoma, apocrine hyperplasia, intraductal hyperplasia, and lobular hyperplasia. FAHB could be present as a localized or diffused pattern in pathology. Most cases show no well-circumscribed mass lesions and no apparent capsules; it is usually identified as an incidental finding in other benign lesions or in random sampling in cancerous breast tissues. FAHB is categorized as a benign proliferative breast disease and it has previously been reported; however, the authors believe this study may be the first case with two giant masses reported. Fiber adenoma hyperplasia is a rare cystic hyperplasia of breast pathology and its ultrasonographic manifestations are easily confused with breast cancer. Comparative MRI ultrasound analysis will help make the differential diagnosis.

Keywords:
Fibroadenomatoid hyperplasia, Proliferative breast disease, Fibroadenomatoid change, Intraductal hyperplasia, Breast pathology
1.
Cheatle GL, Cutler M: Desquamative epithelial hyperplasia: mazoplasia; in Tumors of the Breast. London, Arnold, 1931, pp 77-91.
2.
Liu TH: Diagnostic Pathology. Beijing, People's Medical Publishing House, 1994, pp 566-572.
3.
Wu LS, Chen AY: Ultrasound analysis of fibroadenomatoid hyperplasia of the breast (in Chinese). Chin J Ultrasound Diagn 2001;2:71-73.
4.
Kamal M, Evans AJ, Denley H, Pinder SE, Ellis IO: Fibroadenomatoid hyperplasia: a cause of suspicious microcalcification on mammographic screening. AJR Am J Roentgenol 1998;171:1331-1334.
5.
Yi MG, Hwang MS, Lee JK, Park BH: US findings of fibroadenomatoid hyperplasia of the breast. J Korean Soc Med Ultrasound 2000;19:197-201.
6.
Scholl C: Sonographic features of benign breast masses: a case review. eRADIMAGING 2009;19.
7.
Occhionero M, Restaino G, Ciuffreda M, Carbone A, Sallustio G, Ferrandina G: Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature. Gynecol Obstet Invest 2012;73:260-264.
8.
Perez-Medina T, Orensanz I, Pereira A, Valero de Bernabé J, Engels V, Troyano J, SanFrutos L, Iglesias E: Three-dimensional angioultrasonography for the prediction of malignancy in ovarian masses. Gynecol Obstet Invest 2013;75:120-125.
9.
Sickles EA, Filly RA, Callen PW: Benign breast lesions: ultrasound detection and diagnosis. Radiology 1984;151:467-470.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.